Cargando…

A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue

We analyzed the levels of selected micro-RNAs in normal prostate tissue to assess their potential to indicate tumor foci elsewhere in the prostate. Histologically normal prostate tissue samples from 31 prostate cancer patients and two cancer negative control groups with either unsuspicious or elevat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hellwinkel, Olaf J. C., Sellier, Christina, Sylvester, Yu-Mi Jessica, Brase, Jan C., Isbarn, Hendrik, Erbersdobler, Andreas, Steuber, Thomas, Sültmann, Holger, Schlomm, Thorsten, Wagner, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634476/ https://www.ncbi.nlm.nih.gov/pubmed/23459235 http://dx.doi.org/10.3390/ijms14035239

Ejemplares similares

Serum microRNAs as non-invasive biomarkers for cancer
por: Brase, Jan C, et al.
Publicado: (2010)

Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification
por: Brase, Jan C, et al.
Publicado: (2010)

CD57 Expression in Incidental, Clinically Manifest, and Metastatic Carcinoma of the Prostate
por: Wangerin, Holger, et al.
Publicado: (2014)

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
por: Brase, Jan C, et al.
Publicado: (2011)

Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer
por: Gade, Stephan, et al.
Publicado: (2011)

Prehabilitation Programs Before Radical Prostatectomy: An Interesting Approach that Merits Further Evaluation
por: Isbarn, Hendrik
Publicado: (2020)

ERG Induces Epigenetic Activation of Tudor Domain-Containing Protein 1 (TDRD1) in ERG Rearrangement-Positive Prostate Cancer
por: Kacprzyk, Lukasz A., et al.
Publicado: (2013)

Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation
por: Ummanni, Ramesh, et al.
Publicado: (2011)

Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?
por: Mehring, Gisa, et al.
Publicado: (2023)

Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform
por: Ummanni, Ramesh, et al.
Publicado: (2011)

Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer
por: Burdelski, Christoph, et al.
Publicado: (2014)

Genome-Based Classification and Therapy of Prostate Cancer
por: Angeles, Arlou Kristina, et al.
Publicado: (2018)

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
por: Lotan, Tamara L., et al.
Publicado: (2017)

High mitochondria content is associated with prostate cancer disease progression
por: Grupp, Katharina, et al.
Publicado: (2013)

Diagnostic and Prognostic Potential of MicroRNA Maturation Regulators Drosha, AGO1 and AGO2 in Urothelial Carcinomas of the Bladder
por: Rabien, Anja, et al.
Publicado: (2018)

High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer
por: JACOBSEN, FRANK, et al.
Publicado: (2013)

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer
por: Eichenauer, Till, et al.
Publicado: (2019)

Novel RNA Markers in Prostate Cancer: Functional Considerations and Clinical Translation
por: Pickl, Julia M. A., et al.
Publicado: (2014)

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers()
por: Burdelski, Christoph, et al.
Publicado: (2017)

Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
por: Eickelschulte, Samaneh, et al.
Publicado: (2022)

Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells
por: Willbold, Ramona, et al.
Publicado: (2019)

Correction: Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells
por: Willbold, Ramona, et al.
Publicado: (2020)

Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer
por: Jacobsen, Frank, et al.
Publicado: (2017)

Comparing tumor microRNA profiles of patients with long- and short-term-surviving glioblastoma
por: Schneider, Björn, et al.
Publicado: (2022)

VEGFR-1 Overexpression Identifies a Small Subgroup of Aggressive Prostate Cancers in Patients Treated by Prostatectomy
por: Tsourlakis, Maria Christina, et al.
Publicado: (2015)

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
por: Zabalza, Cristina Villares, et al.
Publicado: (2015)

Outcome of Photoselective Vaporization of the Prostate with the GreenLight-XPS 180 Watt System Compared to Transurethral Resection of the Prostate
por: Reimann, Maximilian, et al.
Publicado: (2019)

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
por: Burdelski, Christoph, et al.
Publicado: (2015)

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer
por: Burdelski, Christoph, et al.
Publicado: (2015)

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
por: Burdelski, Christoph, et al.
Publicado: (2015)

Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age—a statistical analysis
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2023)

The earlier the better? Apalutamide for non-metastatic castration resistant prostate cancer
por: De Santis, Maria, et al.
Publicado: (2019)

Deletion of 8p is an independent prognostic parameter in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2016)

Contamination of multi dose eyedrops in the intra and perioperative context
por: Daehn, Tristan, et al.
Publicado: (2021)

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases
por: Brandi, Franziska, et al.
Publicado: (2018)

Upregulation of centromere protein F is linked to aggressive prostate cancers
por: Göbel, Cosima, et al.
Publicado: (2018)

The Antiapoptotic Function of miR-96 in Prostate Cancer by Inhibition of FOXO1
por: Fendler, Annika, et al.
Publicado: (2013)

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer
por: Melling, Nathaniel, et al.
Publicado: (2015)

No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe
por: Stieler, Kristin, et al.
Publicado: (2011)

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients
por: Tsourlakis, Maria-Christina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i4vhscj297lmj1jc3l0h4g0as4